Buscar

Mostrando ítems 21-30 de 197

Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al Reply

2013- Calaza Cabanas, Manuel; Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio; Montes Martínez, Ariana María; Pérez Pampín, Eva

GENE-BASED ANALYSIS OF A METAANALYSIS OF OSTEOARTHRITIS GENOME WIDE ASSOCIATION STUDIES

2013- Calaza Cabanas, Manuel; Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio; Rodríguez Fontenla, Cristina

COST-UTILITY OF RHEUMATOID ARTHRITIS MONOTHERAPY WITH TOCILIZUMAB IN SPAIN

2013- Gómez-Reino Carnota, Juan Jesús

NUCB2/NESFATIN-1: A NEW ADIPOKINE EXPRESSED IN HUMAN AND MURINE CHONDROCYTES WITH PRO-INFLAMMATORY PROPERTIES

2013- Gómez-Reino Carnota, Juan Jesús; Scotece, Morena; Gualillo ., Oreste; Pino Mínguez, Jesús; Conde Aranda, Javier; [et al.]

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

2013- Gómez-Reino Carnota, Juan Jesús

Apremilast: pooled safety analysis of three phase 3, randomized, controlled trials in patients with psoriatic arthritis

2013- Gómez-Reino Carnota, Juan Jesús

Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

2013- Gómez-Reino Carnota, Juan Jesús

Serum protein biomarkers for response of rheumatoid arthritis to infliximab

2013- Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio; Ortea García, Ignacio

Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: An Asian perspective

2013- Gómez-Reino Carnota, Juan Jesús

Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab

2013- Gómez-Reino Carnota, Juan Jesús

1
2
3
4
5
6
. . .
20